EUVIMEDEUVIMED entdecken
Leserbrief

Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients

Nader Aghakhani, Hamid Soraya iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8194 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Nader Aghakhani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran. Hauptthemen laut MEDLINE: Curcumin, COVID-19 Drug Treatment, Complementary Therapies, Dietary Supplements. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminCOVID-19 Drug TreatmentComplementary TherapiesDietary SupplementsHumansCOVID-19SARS-CoV-2

Substanzen

Curcumin

Autor:innen und Institutionen

  • Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
  • Experimental and Applied Pharmaceutical Research Center, Urmia University of Medical Sciences, Urmia, Iran.

ORCID-Profile: Hamid Soraya

Zitieren

APA

Aghakhani, N., & Soraya, H. (2024). Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients. Phytotherapy Research. https://doi.org/10.1002/ptr.8194

Vancouver

Aghakhani N, Soraya H. Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients. Phytotherapy Research. 2024. doi:10.1002/ptr.8194

BibTeX
@article{Aghakhani2024,
  author = {Aghakhani, Nader and Soraya, Hamid},
  title = {Curcumin supplementation as a complementary and alternative medicine for COVID ‐19 patients},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8194}
}
Kostenlos starten →